Filing Details
- Accession Number:
- 0001410442-17-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-23 15:37:06
- Reporting Period:
- 2017-10-19
- Accepted Time:
- 2017-10-23 15:37:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410442 | Vivek Jain | 951 Calle Amanecer San Clemente CA 92673 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-10-19 | 25,769 | $58.79 | 67,680 | No | 4 | X | Direct | |
Common Stock | Disposition | 2017-10-19 | 25,769 | $190.00 | 41,911 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-10-20 | 72,026 | $58.79 | 113,937 | No | 4 | X | Direct | |
Common Stock | Disposition | 2017-10-20 | 72,026 | $190.00 | 41,911 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | S | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-10-19 | 25,769 | $58.79 | 25,769 | $58.79 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-10-20 | 72,026 | $58.79 | 72,026 | $58.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
554,392 | 2024-02-24 | No | 4 | X | Direct | |
482,366 | 2024-02-24 | No | 4 | X | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017.
- All shares sold were sold at the exact price disclosed.
- Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.